Literature DB >> 31977474

Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.

Yaping Luo, Qingqing Pan, Wen Zhang1, Fang Li.   

Abstract

Contrast CT revealed diffuse enlargement of the pancreas with a suspicious lesion in the uncinate process in a 57-year-old man who presented with jaundice. F-FDG PET/CT showed increased radioactivity in the enlarged pancreas with a nodular lesion with even higher uptake in the uncinate process. To differentiate autoimmune pancreatitis and pancreatic cancer, Ga-FAPI PET/CT was performed. It revealed intense Ga-FAPI uptake in the pancreas, but the FDG-avid lesion in the uncinate process was not shown. The patient was finally diagnosed with pancreatic cancer with tumor-induced pancreatitis with endoscopic ultrasonography-guided biopsy.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31977474     DOI: 10.1097/RLU.0000000000002914

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  23 in total

1.  68Ga-FAPI PET/CT imaging in a patient with thyroiditis.

Authors:  Yue Zhou; Jing He; Yue Chen
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

2.  68Ga-FAPI PET/CT imaging in a patient with primary thyroid lymphoma.

Authors:  Xiao Yang; Weidong Gong; Yue Chen
Journal:  Endocrine       Date:  2021-04-16       Impact factor: 3.633

3.  Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT.

Authors:  Wei Guo; Yizhen Pang; Lanlin Yao; Liang Zhao; Chunlei Fan; Jingpeng Ke; Ping Guo; Bing Hao; Hao Fu; Chengrong Xie; Qin Lin; Hua Wu; Long Sun; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-11       Impact factor: 9.236

4.  Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings.

Authors:  Haojun Chen; Liang Zhao; Dan Ruan; Yizhen Pang; Bing Hao; Yaqing Dai; Xiurong Wu; Wei Guo; Chunlei Fan; Jingxun Wu; Weipeng Huang; Qin Lin; Long Sun; Hua Wu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-25       Impact factor: 9.236

5.  Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis.

Authors:  Yue Zhou; Xin Yang; Huipan Liu; Wenbin Luo; Hanxiang Liu; Taiyong Lv; Junzheng Wang; Jianhua Qin; Santao Ou; Yue Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-07       Impact factor: 9.236

6.  Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.

Authors:  Yizhen Pang; Long Zhao; Qihang Shang; Tinghua Meng; Liang Zhao; Liuxing Feng; Shuangjia Wang; Ping Guo; Xiurong Wu; Qin Lin; Hua Wu; Weipeng Huang; Long Sun; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-15       Impact factor: 9.236

7.  The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [18F]FDG.

Authors:  Lianjun Lan; Hanxiang Liu; Yingwei Wang; Jia Deng; Dengsai Peng; Yue Feng; Li Wang; Yue Chen; Lin Qiu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-19       Impact factor: 9.236

8.  Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas.

Authors:  Xiao Zhang; Wenyu Song; Chunxia Qin; Fang Liu; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-15       Impact factor: 9.236

9.  68Ga-FAPI-04 PET/MR is helpful in differential diagnosis of pancreatitis from pancreatic malignancy compared to 18F-FDG PET/CT: a case report.

Authors:  Yi Shou; Qiaoyi Xue; Jianmin Yuan; Jun Zhao
Journal:  Eur J Hybrid Imaging       Date:  2021-06-15

10.  In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi.

Authors:  Euy Sung Moon; Yentl Van Rymenant; Sandeep Battan; Joni De Loose; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Rösch
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.